AQR Capital Management
TYRA icon

AQR Capital Management’s Tyra Biosciences TYRA Stock Holding History

AQR Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
29,423
+792
+3% +$25.6K ﹤0.01% 2695
2025
Q4 		$753K Buy
28,631
+562
+2% +$10.3K ﹤0.01% 2706
2025
Q3 		$393K Sell
28,069
-643
-2% -$7.33K ﹤0.01% 2936
2025
Q2 		$275K Buy
+28,712
New +$273K ﹤0.01% 2910

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

AQR Capital Management's TYRA Position: Q1 2026 in Review

AQR Capital Management increased its Tyra Biosciences (TYRA) stake by 2.8% in Q1 2026, buying an estimated $25.6K and bringing the position to 29,423 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2695.

AQR Capital Management first reported a position in TYRA in Q2 2025 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • AQR Capital Management held 29,423 shares of Tyra Biosciences worth $1.13M as of Q1 2026.
  • AQR Capital Management bought 792 Tyra Biosciences shares in Q1 2026, an estimated $25.6K.
  • Tyra Biosciences made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2695 holding.
  • AQR Capital Management first reported a position in Tyra Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.